When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Nicholas P. Restifo - Wikipedia

    en.wikipedia.org/wiki/Nicholas_P._Restifo

    Nicholas P. Restifo (born July 24, 1960) is an American immunologist, physician and educator in cancer immunotherapy. Until July 2019, he was a tenured senior investigator in the intramural National Cancer Institute of the National Institutes of Health at Bethesda, Maryland .

  3. List of immunologists - Wikipedia

    en.wikipedia.org/wiki/List_of_immunologists

    Nicholas P. Restifo (1960-) Ivan Roitt (1927-) Jon van Rood (1926-2017), pioneer in the field of HLA and immunogenetics of transplantation, the founder of the international organ exchange organization Eurotransplant; Mario Rosemblatt (1941-), who established that dendritic cells are responsible for imprinting the tissue-specific homing of T ...

  4. Restifo - Wikipedia

    en.wikipedia.org/wiki/Restifo

    Restifo is a surname. Notable people with the surname include: ... Linda Restifo, neuroscientist; Nicholas P. Restifo (born 1960), American immunologist

  5. List of Johns Hopkins University people - Wikipedia

    en.wikipedia.org/wiki/List_of_Johns_Hopkins...

    Nicholas P. Restifo – tumor immunology and immunotherapy Justin B. Ries (Ph.D. 2005) – geoscientist and inventor known for discoveries in the field of global oceanic change Thomas Milton Rivers – virologist, United States Navy Admiral

  6. List of deans and notable people at the NYU Grossman School ...

    en.wikipedia.org/wiki/List_of_deans_and_notable...

    Nicholas P. Restifo, immunologist researcher; Walton T. Roth, psychiatrist researcher; Albert Sabin, Medical researcher, MD, 1931, developer of the oral vaccine for polio and President of the Weizmann Institute of Science; Arthur Sackler, MD, former executive of Purdue Pharma

  7. Dendritic cell-based cancer vaccine - Wikipedia

    en.wikipedia.org/wiki/Dendritic_cell-based...

    The main goal of the therapeutic vaccines is to elicit cellular immunity. [10] They should prime naïve T cell, and induce transition from chronically activated non-protective CD8 + T cells to healthy CD8 + T cells that can produce cytotoxic T lymphocytes (CTLs), which recognize and eliminate cancer cells by recognizing specific antigens.

  8. Nicholas Vecellio wins 2023 Hawley Quier Memorial on sixth ...

    www.aol.com/weather/nicholas-vecellio-wins-2023...

    Aug. 11—A closely contested Hawley Quier Memorial came down to the 18th hole on Friday. And if the spectators standing in the gallery on the par-4 hole of Moselem Springs Golf Club wanted to see ...

  9. Checkpoint inhibitor - Wikipedia

    en.wikipedia.org/wiki/Checkpoint_inhibitor

    Checkpoint inhibitor therapy is a form of cancer immunotherapy.The therapy targets immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an immunologic stimulus.